Metropolitan Life Insurance Company (MetLife)’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,573
| Closed | -$167K | – | 510 |
|
|
2024
Q1 | $167K | Sell |
3,573
-182
| -5% | -$8.52K | 0.01% | 790 |
|
|
2023
Q4 | $134K | Hold |
3,755
| – | – | 0.01% | 934 |
|
|
2023
Q3 | $112K | Buy |
3,755
+906
| +32% | +$26.9K | 0.01% | 953 |
|
|
2023
Q2 | $51.3K | Hold |
2,849
| – | – | ﹤0.01% | 1398 |
|
|
2023
Q1 | $45.8K | Sell |
2,849
-342
| -11% | -$5.49K | ﹤0.01% | 1433 |
|
|
2022
Q4 | $58.4K | Hold |
3,191
| – | – | ﹤0.01% | 1372 |
|
|
2022
Q3 | $62.7K | Hold |
3,191
| – | – | ﹤0.01% | 1302 |
|
|
2022
Q2 | $59.5K | Buy |
3,191
+429
| +16% | +$8K | ﹤0.01% | 1388 |
|
|
2022
Q1 | $60.6K | Sell |
2,762
-9,063
| -77% | -$199K | ﹤0.01% | 1480 |
|
|
2021
Q4 | $336K | Buy |
11,825
+2,165
| +22% | +$61.5K | ﹤0.01% | 1674 |
|
|
2021
Q3 | $203K | Hold |
9,660
| – | – | ﹤0.01% | 2056 |
|
|
2021
Q2 | $182K | Buy |
9,660
+1,974
| +26% | +$37.2K | ﹤0.01% | 2216 |
|
|
2021
Q1 | $117K | Sell |
7,686
-1,106
| -13% | -$16.9K | ﹤0.01% | 2354 |
|
|
2020
Q4 | $124K | Hold |
8,792
| – | – | ﹤0.01% | 2243 |
|
|
2020
Q3 | $138K | Hold |
8,792
| – | – | ﹤0.01% | 2026 |
|
|
2020
Q2 | $154K | Buy |
8,792
+4,619
| +111% | +$80.9K | ﹤0.01% | 1988 |
|
|
2020
Q1 | $61.3K | Hold |
4,173
| – | – | ﹤0.01% | 2317 |
|
|
2019
Q4 | $105K | Buy |
+4,173
| New | +$105K | ﹤0.01% | 2306 |
|
|
2019
Q3 | – | Sell |
-925
| Closed | -$23.1K | – | 2581 |
|
|
2019
Q2 | $23.1K | Buy |
+925
| New | +$23.1K | ﹤0.01% | 2590 |
|